ArticleMaterials (Basel, Switzerland)2022
On the Reuse of SLS Polyamide 12 Powder.
Article in Materials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Functional Materials for Additive Manufacturing: Materials Design, Processing, and Emerging Applications.Nanomaterials (Basel, Switzerland) · 2026Review
- Degradation effects of reused PA12 powder in selective laser sintering on material characteristics, dimensional accuracy and mechanical strength.Scientific reports · 2025Article
- Continuous reuse of polyamide 12 in powder bed fusion.Scientific reports · 2025Article
- Article
- Mechanical properties and biodegradability of samples obtained by 3D printing using FDM technology from PLA filament with by-products.Scientific reports · 2025Article
- The Sound Absorption Performance of Laser-Sintered Composite Biomimetic Wood Porous Structures.Polymers · 2024Article
- Thermomechanical Assessment of Recovered PA12 Powders with Basalt Filler for Automotive Components.Polymers · 2024Article
- Towards the Reuse of Fire Retarded Polyamide 12 for Laser Sintering.Materials (Basel, Switzerland) · 2024Article
- Article
- Glycerol-based sustainably sourced resin for volumetric printing.Green chemistry : an international journal and green chemistry resource : GC · 2024Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the Selective Laser Sintering (SLS) technique, the great majority of the powder involved is not included in the final printed parts, being just used as a support material. However, the quality of this powder is negatively affected during the process since it is subjected to high temperatures (close to its melting temperature) during a long time, i.e., the printing cycle time, especially in the neighborhood of the printed part contour. This type of powder is relatively expensive and large amounts of used powder result after each printing cycle. The present paper focuses on the reuse of Polyamide 12 (PA 12) powder. For this sake, the same PA 12 powder was used in consecutive printing cycles. After each cycle, the remaining non-used powder was milled and filtered before subsequent use. Properties of the powder and corresponding prints were characterized in each cycle, using differential scanning calorimetry (DSC), scanning electron microscopy (SEM), computed tomography (CT), and tensile tests. It was concluded that subjecting the same powder to multiple SLS printing cycles affects the properties of the printed parts essentially regarding their morphology (voids content), mechanical properties reproducibility, and aesthetical aspect. However, post-processing treatment of the powder enabled to maintain the mechanical performance of the prints during the first six printing cycles without the need to add virgin powder.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.